Portal Instruments’ mission is to improve the experience for patients on life-changing therapies by developing innovative, needle-free drug-delivery solutions.  Our patents demonstrate our focus and dedication to transforming drug delivery.


Portal Instruments’ products may be covered by one or more of the following patents. Portal Instruments provides the following patent information pursuant to the virtual patent marking provisions of 35 U.S.C. § 287(a). The patent information provided here is believed to be accurate as of date of the most recent update to this page. But new patents may have issued, or listed patents may have expired, since the page was last updated. Further, the omission or inclusion of any product or patent is not a representation or admission concerning the scope of any patent owned or licensed by Portal Instruments.


Portal Injector:

U.S. 7,833,189

U.S. 8,328,755

U.S. 9,308,326

U.S. 10,413,671

U.S. 10,857,298

U.S. D893,021

U.S. 11786666B2

U.S. 11400220B2

U.S. 11344677B2


Portal Cartridge:

U.S. 10,159,793

U.S. 10,207,055

U.S. D926,970

U.S. D926,971

U.S. D926,972

Portal’s platform is in development and not available for sale or use.